Now Offering ASTYM for Insulin Injection Site Fibrosis

2020-06-03T16:57:41+00:00June 3rd, 2020|Astym, News, Soft Tissue, Treatments|

Diabetes is an increasingly prevalent disease within the United States, with an estimate of 30.3 million people having diabetes as of 2015. That’s roughly 9.4% of the United States populationdiagnosed. Some diabetics require insulin injections to regulate their blood sugar. The insulin is injected into select locations of the body where the fatty tissue is [...]